U.S.
Senator Sherrod Brown
Protecting
Ohioans from Skin Cancer
After
such a long winter, Ohioans are ready to spend more time outside,
enjoying the warmer weather. While doctors recommend that we wear
sunscreen, Americans may be surprised to learn that our sunscreen is
not as effective as the sunscreen sold in Canada and Europe. The
reason? Regulatory gridlock. Regulatory delays have prevented
American sunscreen makers from utilizing many of the ingredients –
particularly those that block harmful UVA rays – that are in
Canadian and European sunscreens.
With
more than two million cases of skin cancer diagnosed in the U.S. each
year, we need access to the most protective sunscreens. Melanoma, the
most deadly type of skin cancer, kills nearly 10,000 Americans
annually.
The
U.S. Food and Drug Administration (FDA), which is tasked with
reviewing sunscreen and other drugs for safety and effectiveness, has
not approved any new sunscreen ingredients in more than 10 years. In
fact, there are at least eight applications for sunscreen ingredients
pending review at the FDA right now. Some of these applications have
been awaiting FDA approval since 2002. Because of this backlog,
companies producing these newer, more effective sunscreens are unable
to sell their products in America.
Ashland
Inc., which manufactures sunscreen ingredients at its Columbus plant,
is one of these companies. The products Ashland makes in Ohio cannot
be sold in Ohio – instead, it is for export only. Ashland submitted
an application to the FDA for approval over four years ago. Because
the FDA has not approved Ashland’s ingredients, the company is
forced to export its product overseas, where it’s been deemed both
safe and effective for more than 10 years.
While
sunscreens sold in the U.S. protect well against UVB rays, there are
only three FDA-approved sunscreen ingredients available in the U.S
that effectively guard against the sun’s UVA rays, which penetrate
deeper into the skin. Europe, on the other hand, has approved seven
sunscreen ingredients that help protect against UVA rays.
I
cosponsored the Sunscreen Innovation Act because Americans’ health
depends on access to safe, effective sun protection. This legislation
would require the FDA to completely review its backlog of pending
sunscreen ingredient applications within eight months and review all
new applications within a year of their submission.
American
consumers should have access to the best sunscreen products
available. The FDA must prioritize its review of sunscreen ingredient
applications so that we can better protect our children and families
against skin cancer.
Sincerely,
Sherrod
Brown
U.S.
Senator
|